0.87 USD
↘ 0.02 (1.82%)LIVE (AS OF 11:36 AM EDT)
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $0.87 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. NAUT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 6, 2026.